Fasting plasma glucose level to guide the need for an OGTT to screen for gestational diabetes mellitus.

Blood Glucose / metabolism Diabetes, Gestational / diagnosis Fasting Female Fetal Macrosomia Glucose Tolerance Test Humans Pregnancy Prospective Studies
Fasting plasma glucose Gestational diabetes mellitus Pregnancy outcomes Screening

Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 17 08 2021
accepted: 07 10 2021
pubmed: 3 11 2021
medline: 25 2 2022
entrez: 2 11 2021
Statut: ppublish

Résumé

To determine the fasting plasma glucose (FPG) level at which an oral glucose tolerance test (OGTT) could be avoided to screen for gestational diabetes (GDM) and to evaluate the characteristics of women across this FPG threshold. A multi-centric prospective cohort study with 1843 women receiving universal screening for GDM with a 75 g OGTT. In the total population, GDM prevalence was 12.5% (231). A FPG < 78 mg/dL was the cut-off with best trade-off to limit the number of missed GDM cases [44 (19.0%)] with a negative predictive value of 97.3% (95% CI 96.5-98.0) for GDM, while avoiding 52.2% OGTTs. Compared to GDM with FPG ≥ 78 mg/dL [187 (81.0%)], GDM women with FPG < 78 mg/dL had a significantly lower BMI (27.1 ± 4.5 vs. 29.6 ± 5.2 kg/m FPG < 78 mg/dL can be used to limit the number of OGTTs when screening for GDM. Women with FPG < 78 mg/dL had a better metabolic profile and in NGT women also less fetal overgrowth.

Identifiants

DOI: 10.1007/s00592-021-01812-9 PMID: 34725724
pubmed: 34725724
doi: 10.1007/s00592-021-01812-9
pii: 10.1007/s00592-021-01812-9
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-394

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021. Springer-Verlag Italia S.r.l., part of Springer Nature.

Références

American Diabetes Association (2021) Addendum. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care 44(Suppl. 1):S15–S33. https://doi.org/10.2337/dc21-ad09
doi: 10.2337/dc21-ad09
Crowther CA, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352(24):2477–2486. https://doi.org/10.1056/NEJMoa042973
doi: 10.1056/NEJMoa042973 pubmed: 15951574
Landon MB, Spong CY, Thom E et al (2009) A multicenter randomized trial of treatment for mild gestational diabetes. N Engl J Med 361(14):1339–48. https://doi.org/10.1056/NEJMoa0902430
doi: 10.1056/NEJMoa0902430 pubmed: 19797280 pmcid: 2804874
Benhalima K, Mathieu C, Damm P et al (2015) A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG). Diabetologia 58(7):1422–9. https://doi.org/10.1007/s00125-015-3615-7
doi: 10.1007/s00125-015-3615-7 pubmed: 25952480
O’Sullivan JB, Mahan CM (1964) Criteria for the oral glucose tolerance test in pregnancy. Diabetes 13:278–285
pubmed: 14166677
Carpenter MW, Coustan DR (1982) Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144(7):768–773. https://doi.org/10.1016/0002-9378(82)90349-0
doi: 10.1016/0002-9378(82)90349-0 pubmed: 7148898
Metzger BE, Buchanan TA, Coustan DR et al (2007) Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care 30(Suppl 2):S251-60. https://doi.org/10.2337/dc07-s225
doi: 10.2337/dc07-s225 pubmed: 17596481
Metzger BE et al (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3):676–682. https://doi.org/10.2337/dc09-1848
doi: 10.2337/dc09-1848 pubmed: 20190296
Metzger BE, Contreras M, Sacks DA et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358(19):1991–2002. https://doi.org/10.1056/NEJMoa0707943
doi: 10.1056/NEJMoa0707943 pubmed: 18463375
Agarwal MM, Punnose J, Dhatt GS (2004) Gestational diabetes: problems associated with the oral glucose tolerance test. Diabetes Res Clin Pract 63(1):73–74. https://doi.org/10.1016/j.diabres.2003.08.005
doi: 10.1016/j.diabres.2003.08.005 pubmed: 14693415
Benhalima K, Van Crombrugge P, Moyson C et al (2018) A Modified two-step screening strategy for gestational diabetes mellitus based on the 2013 WHO criteria by combining the glucose challenge test and clinical risk factors. J Clin Med 7(10):351. https://doi.org/10.3390/jcm7100351
doi: 10.3390/jcm7100351 pubmed: 30322138 pmcid: 6210855
Agarwal MM (2016) Gestational diabetes mellitus: Screening with fasting plasma glucose. World J Diabetes 7(14):279–289. https://doi.org/10.4239/wjd.v7.i14.279
doi: 10.4239/wjd.v7.i14.279 pubmed: 27525055 pmcid: 4958688
Benhalima K, Mathieu C, Van Assche A et al (2016) Survey by the European Board and College of Obstetrics and Gynaecology on screening for gestational diabetes in Europe. Eur J Obstet Gynecol Reprod Biol 201:197–202. https://doi.org/10.1016/j.ejogrb.2016.04.003
doi: 10.1016/j.ejogrb.2016.04.003 pubmed: 27129745
Li M, Lan JR, Liang JL, Xiong XL (2020) Diagnostic accuracy of fasting plasma glucose as a screening test for gestational diabetes mellitus: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 24(21):11172–11186. https://doi.org/10.26355/eurrev_202011_23605
doi: 10.26355/eurrev_202011_23605 pubmed: 33215435
Benhalima K, Van Crombrugge P, Verhaeghe J et al (2014) The Belgian diabetes in pregnancy study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design. BMC Pregnancy Childbirth 14:226. https://doi.org/10.1186/1471-2393-14-226
doi: 10.1186/1471-2393-14-226 pubmed: 25015413 pmcid: 4227277
Benhalima K, Van Crombrugge P, Moyson C et al (2018) The sensitivity and specificity of the glucose challenge test in a universal two-step screening strategy for gestational diabetes mellitus using the 2013 world health organization criteria. Diabetes Care 41(7):e111–e112. https://doi.org/10.2337/dc18-0556
doi: 10.2337/dc18-0556 pubmed: 29748432
Benhalima K, Van Crombrugge P, Moyson C et al (2019) Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance. Diabetologia 62(11):2118–2128. https://doi.org/10.1007/s00125-019-4961-7
doi: 10.1007/s00125-019-4961-7 pubmed: 31338546
American Diabetes Association (2013) Standards of medical care in diabetes-2013. Diabetes Care 36(Suppl 1):S11-66. https://doi.org/10.2337/dc13-S011
doi: 10.2337/dc13-S011
Durán A, Martín P, Runkle I et al (2010) Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes 2(3):203–211. https://doi.org/10.1111/j.1753-0407.2010.00081.x
doi: 10.1111/j.1753-0407.2010.00081.x pubmed: 20923485
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419. https://doi.org/10.1007/BF00280883
doi: 10.1007/BF00280883 pubmed: 3899825
Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470. https://doi.org/10.2337/diacare.22.9.1462
doi: 10.2337/diacare.22.9.1462 pubmed: 10480510
Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46(1):3–19. https://doi.org/10.1007/s00125-002-1009-0
doi: 10.1007/s00125-002-1009-0 pubmed: 12637977
Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM (2001) Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 24(9):1602–1607. https://doi.org/10.2337/diacare.24.9.1602
doi: 10.2337/diacare.24.9.1602 pubmed: 11522706
Retnakaran R, Qi Y, Goran MI, Hamilton JK (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 26(12):1198–1203. https://doi.org/10.1111/j.1464-5491.2009.02841.x
doi: 10.1111/j.1464-5491.2009.02841.x pubmed: 20002470
Devlieger H, Martens G, Bekaert A, Eeckels R (2000) Standaarden van geboortegewicht-voor-zwangerschapsduur voor de vlaamse boreling. Tijdschrift voor geneeskunde 56(1):1–14
doi: 10.2143/TVG.56.1.5000625
IOM (Institute of Medicine) and NRC (National Research Council) (2009) Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC.
Saeedi M, Hanson U, Simmons D, Fadl H (2018) Characteristics of different risk factors and fasting plasma glucose for identifying GDM when using IADPSG criteria: a cross-sectional study. BMC Pregnancy Childbirth 18(1):225. https://doi.org/10.1186/s12884-018-1875-1
doi: 10.1186/s12884-018-1875-1 pubmed: 29898685 pmcid: 6001029
d’Emden M, McLeod D, Ungerer J, Appleton C, Kanowski D (2020) Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment. PLoS ONE 15(12):e0243192. https://doi.org/10.1371/journal.pone.0243192
doi: 10.1371/journal.pone.0243192 pubmed: 33270719 pmcid: 7714128
Perucchini D, Fischer U, Spinas GA, Huch R, Huch A, Lehmann R (1999) Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study. BMJ 319(7213):812–815. https://doi.org/10.1136/bmj.319.7213.812
doi: 10.1136/bmj.319.7213.812 pubmed: 10496823 pmcid: 314206
Agarwal MM, Dhatt GS, Shah SM (2010) Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care 33(9):2018–2020. https://doi.org/10.2337/dc10-0572
doi: 10.2337/dc10-0572 pubmed: 20519664 pmcid: 2928355
Agarwal MM, Hughes PF, Punnose J, Ezimokhai M (2000) Fasting plasma glucose as a screening test for gestational diabetes in a multi-ethnic, high-risk population. Diabet Med 17(10):720–726. https://doi.org/10.1046/j.1464-5491.2000.00371.x
doi: 10.1046/j.1464-5491.2000.00371.x pubmed: 11110505
Agarwal MM, Dhatt GS, Punnose J (2006) Gestational diabetes: utility of fasting plasma glucose as a screening test depends on the diagnostic criteria. Diabet Med 23(12):1319–1326. https://doi.org/10.1111/j.1464-5491.2006.01987.x
doi: 10.1111/j.1464-5491.2006.01987.x pubmed: 17116182
Agarwal MM, Dhatt GS, Punnose J, Koster G (2005) Gestational diabetes in a high-risk population: using the fasting plasma glucose to simplify the diagnostic algorithm. Eur J Obstet Gynecol Reprod Biol 120(1):39–44. https://doi.org/10.1016/j.ejogrb.2004.07.034
doi: 10.1016/j.ejogrb.2004.07.034 pubmed: 15866084
Pintaudi B, Di Vieste G, Corrado F et al (2014) Improvement of selective screening strategy for gestational diabetes through a more accurate definition of high-risk groups. Eur J Endocrinol 170(1):87–93. https://doi.org/10.1530/EJE-13-0759
doi: 10.1530/EJE-13-0759 pubmed: 24114434
Balaji V, Balaji M, Anjalakshi C, Cynthia A, Arthi T, Seshiah V (2011) Inadequacy of fasting plasma glucose to diagnose gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract 94(1):e21–e23. https://doi.org/10.1016/j.diabres.2011.07.008
doi: 10.1016/j.diabres.2011.07.008 pubmed: 21831468
Juutinen J, Hartikainen AL, Bloigu R, Tapanainen JS (2000) A retrospective study on 435 women with gestational diabetes: fasting plasma glucose is not sensitive enough for screening but predicts a need for insulin treatment. Diabetes Care 23(12):1858–1859. https://doi.org/10.2337/diacare.23.12.1858
doi: 10.2337/diacare.23.12.1858 pubmed: 11128372
Maegawa Y, Sugiyama T, Kusaka H, Mitao M, Toyoda N (2003) Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy. Diabetes Res Clin Pract 62(1):47–53. https://doi.org/10.1016/s0168-8227(03)00146-3
doi: 10.1016/s0168-8227(03)00146-3 pubmed: 14581157
McIntyre HD, Gibbons KS, Ma RCW et al (2020) Testing for gestational diabetes during the COVID-19 pandemic. An evaluation of proposed protocols for the United Kingdom, Canada and Australia. Diabetes Res Clin Pract 167:108353. https://doi.org/10.1016/j.diabres.2020.108353
doi: 10.1016/j.diabres.2020.108353 pubmed: 32739381 pmcid: 7391984
McIntyre HD, Moses RG (2020) The diagnosis and management of gestational diabetes mellitus in the context of the COVID-19 pandemic. Diabetes Care 43(7):1433–1434. https://doi.org/10.2337/dci20-0026
doi: 10.2337/dci20-0026 pubmed: 32409503
Pintaudi B, Fresa R, Dalfrà M et al (2018) The risk stratification of adverse neonatal outcomes in women with gestational diabetes (STRONG) study. Acta Diabetologia 55(12):1261–1273. https://doi.org/10.1007/s00592-018-1208-x
doi: 10.1007/s00592-018-1208-x

Auteurs

Kaat Beunen (K)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. kaat.beunen@kuleuven.be.
ORCID: 0000-0003-3557-0022

Astrid Neys (A)

KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Paul Van Crombrugge (P)

Department of Endocrinology, OLV Ziekenhuis Aalst-Asse-Ninove, Moorselbaan 164, 9300, Aalst, Belgium.

Carolien Moyson (C)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Johan Verhaeghe (J)

Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Sofie Vandeginste (S)

Department of Obstetrics and Gynecology, OLV Ziekenhuis Aalst-Asse-Ninove, Moorselbaan 164, 9300, Aalst, Belgium.

Hilde Verlaenen (H)

Department of Obstetrics and Gynecology, OLV Ziekenhuis Aalst-Asse-Ninove, Moorselbaan 164, 9300, Aalst, Belgium.

Chris Vercammen (C)

Department of Endocrinology, Imelda Ziekenhuis, Imeldalaan 9, 2820, Bonheiden, Belgium.

Toon Maes (T)

Department of Endocrinology, Imelda Ziekenhuis, Imeldalaan 9, 2820, Bonheiden, Belgium.

Els Dufraimont (E)

Department of Obstetrics and Gynecology, Imelda Ziekenhuis, Imeldalaan 9, 2820, Bonheiden, Belgium.

Nele Roggen (N)

Department of Obstetrics and Gynecology, Imelda Ziekenhuis, Imeldalaan 9, 2820, Bonheiden, Belgium.

Christophe De Block (C)

Department of Endocrinology-Diabetology-Metabolism, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium.

Yves Jacquemyn (Y)

Department of Obstetrics and Gynecology, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium.

Farah Mekahli (F)

Department of Endocrinology, Kliniek St-Jan Brussel, Kruidtuinlaan 32, 1000, Brussel, Belgium.

Katrien De Clippel (K)

Department of Obstetrics and Gynecology, Kliniek St-Jan Brussel, Kruidtuinlaan 32, 1000, Brussel, Belgium.

Annick Van Den Bruel (A)

Department of Endocrinology, AZ St Jan Brugge, Ruddershove 10, 8000, Brugge, Belgium.

Anne Loccufier (A)

Department of Obstetrics and Gynecology, AZ St Jan Brugge, Ruddershove 10, 8000, Brugge, Belgium.

Annouschka Laenen (A)

Center of Biostatics and Statistical Bioinformatics, KU Leuven, Kapucijnenvoer 35 bloc d, box 7001, 3000, Leuven, Belgium.

Roland Devlieger (R)

Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Chantal Mathieu (C)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Katrien Benhalima (K)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Glucides › Sucres › Oses › Hexose › Glucose › Glycémie › Fasting plasma glucose level to guide the need...
questionsmedicales.fr › Maladies endocriniennes › Diabète › Diabète gestationnel › Fasting plasma glucose level to guide the need...
questionsmedicales.fr › Phénomènes physiologiques › Alimentation et nutrition › Phénomènes physiologiques nutritionnels › Comportement alimentaire › Jeûne › Fasting plasma glucose level to guide the need...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Macrosomie foetale › Fasting plasma glucose level to guide the need...
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Tests de chimie clinique › Analyse chimique du sang › Hyperglycémie provoquée › Fasting plasma glucose level to guide the need...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Fasting plasma glucose level to guide the need...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Grossesse › Fasting plasma glucose level to guide the need...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Fasting plasma glucose level to guide the need...